Peak Retirement Planning Inc. Purchases New Position in Colgate-Palmolive (NYSE:CL)

Peak Retirement Planning Inc. bought a new stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,720 shares of the company's stock, valued at approximately $792,000.

Other hedge funds also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive in the fourth quarter worth approximately $32,000. Finally, Wintrust Investments LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $33,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

CL stock traded down $0.16 during trading on Tuesday, reaching $92.43. 6,055,170 shares of the stock were exchanged, compared to its average volume of 4,683,281. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $74.91 billion, a P/E ratio of 26.26, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39. The stock has a 50 day simple moving average of $91.85 and a 200-day simple moving average of $91.25.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter last year, the company earned $0.86 EPS. The company's quarterly revenue was down 3.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its board has authorized a share buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.25%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 58.76%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Barclays lowered their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. Raymond James restated an "outperform" rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Citigroup increased their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. Finally, Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $102.12.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.